Skip to main content
Article
162 Efficacyand safety of certolizumab pegol over four years in psoriatic arthritis patientswith and without concomitant use of DMARDs
Rheumatology (2018)
  • Robert G Cooper, University of Liverpool
  • Jessica Walsh, University of Utah
  • Alice B Gottlieb, New York Medical College
  • Bengt Hoepken, UCB
  • Tommi Nurminen, UCB
  • Philip J Mease, University of Washington
Publication Date
April 1, 2018
DOI
10.1093/rheumatology/key075.386
Citation Information
Robert G Cooper, Jessica Walsh, Alice B Gottlieb, Bengt Hoepken, et al.. "162 Efficacyand safety of certolizumab pegol over four years in psoriatic arthritis patientswith and without concomitant use of DMARDs" Rheumatology Vol. 57 (2018)
Available at: http://works.bepress.com/philip-mease/6/